Featured Image
Perspectives
It is unclear how the data used by the CLSI could have been considered sufficiently credible to prove that ESBLs do not matter and that laboratories only need to report MICs, a position that conflicts with therapeutic outcome data and expert opinion .
Dr Kenneth S Thomson
University of Louisville
Read the Original
This page is a summary of: Lowering of Third Generation Cephalosporin Breakpoints, Clinical Infectious Diseases, September 2013, Oxford University Press (OUP),
DOI: 10.1093/cid/cit569.
You can read the full text:
Contributors
The following have contributed to this page
